Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Maori Surviving Prostate Cancer The Midlands Prostate Cancer Study Kaumātua on the paepae at Turangawaewae Photograph from Waikato‐Tainui. Nina Scott, Ngati Whatua, Waikato, FNZCPHM, MPH, MBChB through the organised efforts of society . . . suffering from cancer is largely avoidable Prostate cancer is a priority for Maori cancer control Every year; 170 Maori men diagnosed 45 Maori men die 3rd most common cancer 5th most common cause of cancer death Maori 28% less likely to be diagnosed 52% more likely to die than non-Maori Prostate cancer is a priority for Maori cancer control Maori 28% less likely to be diagnosed: 84.4 per 100,000 Māori 117.9 per 100,000 non‐Māori 52% more likely to die than non-Maori: 25.5 per 100,000 Māori 16.8 per 100,000 non‐Māori Inequities are differences which are Unfair Avoidable Fixable • Monitor the crown • Right to health • Quality improvement Inequities are low hanging cancer control fruit Non‐standardised care = inequities Inequities highlight where standardisation is needed first Inequities are an indicator of what could be achieved at a minimum for Maori tell us where we can get relatively quick gains for cancer control Assume inequities occur at every step of cancer pathway . . . unless proven otherwise Diagnosed late, referred late, seen late, offered treatment late, receive treatment late, receive lower quality treatment Small inequities add up to inequities big important Maori 10% less likely to be diagnosed 60% more likely to die •“The most likely explanation for this is that Maori have a cultural reluctance to present for health care” Non‐standardised care along the pathway Maori testing screening Maori Maori High PSA Specialist referral Maori Biopsy Maori Inequities continued . . . Maori Cancer found from biopsy Maori Surgery for localised cancer Maori Radiotherapy for localised cancer Maori Surgical removal of testicles Receive medication for erectile dysfunction Maori Men diagnosed with PC in NZ over 15 yrs 1,916 Māori (5.1%) men out of 37,529 men, 40+ yrs PC diagnosed 1996‐2011 NZ Cancer Registry – NHI link ‐ Mortality Collection NZCR – extent recorded for only ¼. Dr Zuzana Obertova Māori % Age at Diagnosis: < 70 yrs older non‐Māori % 59 49 41 51 55 69 28 22 17 10 Deprivation: 1‐3 (least deprived) 10 28 4‐7 31 43 59 29 52 61 24 16 25 22 70+ yrs Residence: Main urban area Less urban Urban influence Rural/remote area 8‐10 (most deprived) Vital status: Alive Died of prostate cancer Died of other causes More remote 2 x more deprived More likely to have died “a state of observable and demonstrable disadvantage relative to the local community or the wider society or nations to which an individual, family or group belongs.” (Townsend, 1987) Factors incorporated in NZDep96 Age‐standardised incidence rate per 100,000 Diagnosis of prostate cancer 1996 ‐2010 400.0 350.0 300.0 250.0 200.0 150.0 100.0 50.0 0.0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Maori non‐Maori Total 1800 1500 1200 900 600 300 0 19 96 19 97 19 98 19 99 20 00 20 01 20 02 20 03 20 04 20 05 20 06 20 07 20 08 20 09 20 10 Age‐standrdised incidence rate per 100,000 Diagnosis of prostate cancer increases with age Maori 40‐54y Maori 55‐74y Maori 75+y non‐Maori 40‐54y non‐Maori 55‐74y non‐Maori 75+y Survival for men diagnosed with PC in NZ 1996‐2011 Kaplan‐Meier method 100 Proportion surviving (%) 90 80 70 60 50 40 30 20 10 0 1 year Maori AC 5 years non‐Maori AC Maori CS 10 years non‐Maori CS AC: all‐cause; CS: cancer‐specific Prostate cancer survival has improved over time but inequities haven't 1996‐2011 Kaplan‐Meier method Survival for men diagnosed with PC in NZ 1996‐2011 Cox proportional hazards regression model All‐cause Adjusted for Hazard ratio 95% confidence interval age 1.93 1.81 ‐ 2.07 age, year of diagnosis, residence, deprivation 1.84 1.72 ‐ 1.97 Cancer‐specific Adjusted for Hazard ratio 95% confidence interval age 2.09 1.90 ‐ 2.30 age, year of diagnosis, residence, deprivation 1.94 1.76 ‐ 2.14 <70 yrs 2.28 1.97 ‐ 2.64 ‐ age, year of diagnosis, residence, deprivation 2.62 Regional spread 1.60, 4.31 Regional spread 2.62 1.60 ‐ 4.31 ‐‐ age, year of diagnosis, residence, deprivation age, year of diagnosis, residence, deprivation Metastatic ‐ age, year of diagnosis, residence, deprivation 1.32 1.11, 1.58 through the organised efforts of society . . . suffering from cancer is largely avoidable “Get it right for Maori get it right for all’ . . . identify inequities then standardise care where inequities occur